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Epidemiologic studies seldom include wealth as a component of socioeconomic status. The authors investigated
the associations between wealth and 2 broad outcome measures: mortality and self-rated general health status.
Data from the longitudinal Panel Study of Income Dynamics, collected in a US population between 1984 and 2005,
were used to fit marginal structural models and to estimate relative and absolute measures of effect. Wealth was
specified as a 6-category variable: those with 0 wealth and quintiles of positive wealth. There were a 16%–44%
higher risk and 6–18 excess cases of poor/fair health (per 1,000 persons) among the less wealthy relative to the
wealthiest quintile. Less wealthy men, women, and whites had higher risk of poor/fair health relative to their wealthy
counterparts. The overall wealth–mortality association revealed a 62% increased risk and 4 excess deaths (per
1,000 persons) among the least wealthy. Less wealthy women had between a 24% and a 90% higher risk of death,
and the least wealthy men had 6 excess deaths compared with the wealthiest quintile. Overall, there was a strong
inverse association between wealth and poor health status and between wealth and mortality.
health status; inverse probability weighting; marginal structural model; mortality; socioeconomic status; wealth
Abbreviations: CI, confidence interval; RD, risk difference; RR, risk ratio; SRH, self-rated health status.
The goal of this study was to explore the association
between an uncommonly used measure of socioeconomic
status (wealth) and 2 health outcomes (self-rated health sta-
tus (SRH) and mortality). Wealth, the stockpile of resources
amassed over the lifetime, differs from income, which is the
flow of resources into the household (1).
Previous studies have found a consistent causal associa-
tion between wealth and mortality: As wealth increases,
mortality declines (2–7). The previous literature on the
causal direction between wealth and SRH (and other health
outcomes), however, is mixed. Although several studies
have found that less wealth results in poorer health (8–16),
others have found a more compelling argument for the ef-
fects working in the other direction, with poor health re-
sulting in a decline in wealth (17–20). There is also some
speculation that the wealth–morbidity association may be
attributable to an unmeasured confounder. Although our
study cannot address all potential sources of bias, it does
better enable us to manage concerns expressed in prior stud-
ies. First, our use of marginal structural models produces
improved estimates by better managing time-varying con-
founding. In addition, we provide both relative and absolute
measures of effect and a longer follow-up time than other
studies. Given these methodological improvements, we
hope to more effectively address the question: Do the weal-
thy have a health advantage?
MATERIALS AND METHODS
We used data from the Panel Study of Income Dynamics,
an ongoing longitudinal study of the US population that
began in 1968. The design and content of the Panel Study
have been previously described (21). Data for this study
came from 7 waves of the Panel Study: 1984, 1989, 1994,
1999, 2001, 2003, and 2005. Health questions were asked
only of the head of household and his/her partner.
Measures
The health outcomes examined in this study were SRH
and mortality. The SRH variable was derived from the
192 Am J Epidemiol 2011;173:192–200
standard question, ‘‘Would you say your health in general is
excellent, very good, good, fair, or poor?’’ In keeping with
several other papers on wealth and health, it was dichoto-
mized as excellent, very good, or good (coded as 0) versus
fair or poor (coded as 1). Deaths were verified by using the
National Death Index. However, the mortality status of re-
spondents who were lost to follow-up was not matched to
the National Death Index; thus, their vital status is unknown
(22). The maximum follow-up time for mortality was 21
years (1984–2005) with a median of 17 years.
Family wealth in the Panel Study of Income Dynamics is
well-measured and consistent with that from other studies
(23). It was defined as total net worth, which includes the
value of one’s primary home, farm, or business assets,
checking or savings accounts, vehicles, second homes,
stocks, and bonds minus any debt. Wealth was adjusted
for inflation by using the 2001 consumer price index and
specified as a 6-category variable, where category 1 in-
cluded all those that had0 wealth, and categories 2–6 were
quintiles of positive wealth. Wealth quintiles were based on
the distribution of wealth for each survey year. In the final
models, wealth was specified as 5 indicator terms to avoid
making any assumptions about linearity. The referent group
was the highest wealth quintile. For stratified models,
wealth categories were redefined for only the population
of interest; for example, the model for women defined
wealth categories only among women. Models using al-
ternative specifications of wealth are available in Web
Tables 1–3, which are available on the Journal’s Web site
(http://aje.oxfordjournals.org/).
Income, marital status, region of residence, education,
age, race, sex, and time were included as covariates for both
outcomes. Income was specified as a continuous poverty/
income ratio using the annual poverty thresholds from the
Census Bureau that accounts for household size (24). Mar-
ital status was categorized as married (referent group), never
married or divorced, separated, or widowed and specified as
indicator terms. The 3 indicator variables for region classi-
fied state of residence as Northeast, Midwest, or South; West
was the referent group. Education was specified as 2 indi-
cator variables (less than high school and high school de-
gree), and greater than high school was the referent group.
Age was specified as a continuous centered variable for both
outcomes. An indicator variable for race included all non-
white participants, which in the Panel Study of Income Dy-
namics consists mostly of African Americans, and the
referent group was non-Hispanic white. Time was specified
as a continuous variable and a cubic spline with knots at the
5th, 27.5th, 50th, 72.5th, and 95th percentiles. The mortality
model also included baseline (and time-varying) SRH as
a dichotomized covariate. Given the heterogeneity in wealth
distribution by race and gender (1), we included race- and
gender-stratified models for both mortality and SRH.
Statistical analysis
Adjusted associations were estimated by using both ab-
solute (risk differences) and relative (risk ratio) measures of
effect for the total population and by gender and race sep-
arately. For SRH, a binomial marginal structural model
yielded adjusted risk ratios directly. For mortality, a cumu-
lative incidence model, fitted with a logistic marginal struc-
tural model, was used to ascertain risk of death. Results
from a Cox model were similar to those from the cumulative
incidence model. Marginal structural models are effective
in controlling for time-varying confounders; these are cova-
riates that act as both confounders and mediators simulta-
neously (25). Risk differences were calculated by taking
the differences between predicted probabilities estimated
from a logistic marginal structural model. The delta method
was used to estimate the variances for risk differences
(26) via the marginal effects postestimation procedures
available in STATA, version 10, software (27). Risk differ-
ences were calculated by holding all covariates at their mean
values, which correspond to standardization of the effect
estimates to the covariate distribution in the total study
population (28).
The use of survey weights when analyzing data from the
Panel Study of Income Dynamics produces nationally rep-
resentative estimates. However, survey weights were not
used in the current analysis, because we are interested in
a substantive hypothesis rather than population representa-
tive prevalence estimates; thus, parameters estimated in our
models have in-sample interpretations and are not applica-
ble to the broader US population. Furthermore, survey
weights from the Panel Study of Income Dynamics account
for attrition. We calculated a censoring weight (discussed
below) that serves a similar purpose.
The time-varying confounders for SRH were income and
marital status; for mortality, SRH was also included. The
main exposure, wealth, was time varying. Sex, race, age,
education, and region were ascertained at baseline and
treated as time invariant. Baseline values for all time-
varying confounders were also included in the final marginal
structural model. In SRH models, starting values from
Poisson regression were used if binomial models did not
converge (29).
In households where both the head of household and
partner were present, there was clustering by household.
Furthermore, there was 1 observation per time point per
person, resulting in additional clustering by individual. We
adjusted the variances for clustering at the highest level of
aggregation, the household, which produced valid estimates
by accounting for both sources of dependence (30, 31). For
the SRH analysis, individuals who reported poor SRH at
baseline were excluded, and only the first incidence of poor
or fair SRH was modeled. Participants entered the study
between 1984 and 2003 as long as they participated in more
than 1 year of data collection. Those with only 1 wave of
data collection were excluded, because they did not accrue
person-time.
Inverse probability weights
Inverse probability weights control for time-varying
confounding by creating a so-called pseudopopulation
(25). Inverse probability weights were estimated from pre-
dicted probabilities obtained from logistic and multinomial
models. Logistic models were used to obtain censoring
weights, where the outcome of interest was whether or not
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an individual was lost to follow-up at that time point. Mul-
tinomial (i.e., proportional odds) models were used to obtain
treatment weights; the 6-category wealth variable was the
outcome. Multiplying the treatment and censoring weights
resulted in the final inverse probability weight. In the
weighting model, continuous variables, income and age
(centered on the mean), were specified flexibly; age was
specified as a linear term, squared term, and 2 quadratic
splines, and income was specified as linear, squared, and
cubic terms. Because these are stabilized inverse probability
weight, the numerator of the weight contains all baseline
covariates, while the denominator contains baseline and
time-varying confounders. Several weighting models were
tested, and the best one was chosen depending on the dis-
tribution of the inverse probability weight. Desirable prop-
erties for the inverse probability weight are a mean close to
1 and a small range (25, 32).
Very large values of the stabilized weight or means far
from 1 indicated a possible violation of the positivity as-
sumption or a misspecified weighting model. One strategy
used to deal with extreme weights is to truncate or trim the
weights (32). Depending on the model, 2% or 3% of the
inverse probability weight was trimmed at each end. How-
ever, 5% of the inverse probability weight was trimmed in
the mortality and SRH model for men. Trimming the
weights resulted in means close to 1 and a much narrower
range of values; however, it also resulted in less control for
known confounders.
RESULTS
There were 26,615 persons that were either heads of
household or partners for at least 1 wave between 1984
and 2005 in the Panel Study of Income Dynamics. The
mortality analysis used this full sample. After excluding
2,419 participants with fair or poor health status at base-
line and 8,451 with 1 wave of data collection, the final
sample size for the SRH analysis was 15,745. Overall, there
were 2,162 deaths (8.12%), and the prevalence of poor or
fair health status was 16.4% at baseline. The age range for
the full sample at baseline was 18–95 years of age.
Table 1 provides demographic characteristics overall and
by quintiles of wealth for the full study population. After
adjustment for inflation, the median wealth at baseline was
approximately $17,925, but the mean wealth was close to
$101,600, indicating the highly skewed nature of household
wealth. The percentage in the poorest wealth category was
higher for women compared with men (about 57.6% vs.
42.4%). As wealth increased, however, the male/female
gap declined and was nearly eliminated at the highest quin-
tile of wealth. In the wealthiest quintile, the proportion of
white respondents to nonwhites was 6 times as high, while
in the poorest wealth category the gap was reduced to about
1.5 times as high. Older, more educated, and higher income
individuals had much more wealth than their younger, less
educated, and lower income counterparts. For these 3 char-
acteristics, there was a steady trend (Ptrend < 0.0001).
Among the highest quintile of wealth, there were far more
married persons (84.8%) compared with the never married
(5.4%) or widowed, divorced, or separated (9.8%). In the
crude analysis, the percentage of persons reporting poor
SRH declined as wealth increased, but the percentage of
deaths increased with greater wealth (because of increas-
ing age). All bivariate analyses presented in Table 1 had
P < 0.001.
Wealth and SRH
As seen in Table 2, there was a strong association between
SRH and wealth on both the relative and absolute scales. In
the fully adjusted binomial model, as wealth increased the
risk of poor SRH declined. Those with 0 wealth and those
in quintile 1 had a higher risk of poor SRH relative to the
wealthiest quintile (risk ratio (RR) ¼ 1.42, 95% confidence
interval (CI): 1.17, 1.74 and RR¼ 1.44, 95% CI: 1.21, 1.72),
respectively. Those in quintiles 2–4 also had an elevated risk
of poor health (RR ¼ 1.19, 95% CI: 1.00, 1.42; RR ¼ 1.20,
95% CI: 1.02, 1.41; and RR ¼ 1.16, 95% CI: 1.00, 1.36,
respectively) relative to the wealthiest quintile.
Risk differences were expressed as the number of excess
cases of poor health attributable to having lower wealth in-
stead of high wealth (quintile 5) per 1,000 persons from
1984 to 2005 (Figure 1). After adjustment for covariates,
among those with 0 wealth, there were 18 (95% CI: 10,
26) excess cases, in quintile 1 there were 15 (95% CI: 8, 22),
and in quintile 2 there were 7 (95% CI: 1, 14). Quintiles 3
and 4 had 7 (95% CI: 1, 13) and 6 (95% CI: 0, 11) excess
cases of poor health, respectively.
Stratified models for SRH revealed a similar pattern
(Table 3). Among men and whites, the least wealthy had
a higher risk of poor health on the risk ratio and risk differ-
ence scales (for men, RR ¼ 1.41, 95% CI: 1.02, 1.96,
risk difference (RD) ¼ 21, 95% CI: 9, 33; for whites,
RR ¼ 1.89, 95% CI: 1.47, 2.44, RD ¼ 22, 95% CI:
11, 33) compared with the wealthier quintiles. Among
women, those with 0 wealth had a similarly elevated risk
of poor health as those in quintile 1 (RR ¼ 1.73, 95% CI:
1.33, 2.25 and RR¼ 1.82, 95% CI: 1.43, 2.31, respectively).
The binomial model for nonwhites showed a near-null as-
sociation for the poorest wealth quintiles and suggested
a protective effect for the wealthier quintiles (although
confidence intervals included 1).
Wealth and mortality
In the mortality analysis, on both the relative and absolute
scales, there was an increased risk of death among less
wealthy groups. As seen in Table 2, those with 0 wealth
had a 62% higher risk of death compared with the wealthiest
group (95% CI: 1.29, 2.05). Low-wealth quintiles 1 and 2
had similarly elevated risks of death of 29% (95% CI: 1.03,
1.62) and 31% (95% CI: 1.05, 1.64), respectively, while the
risk of death fell for those in quintiles 3 (RR ¼ 1.26, 95%
CI: 1.03, 1.55) and 4 (RR ¼ 1.17, 95% CI: 0.97, 1.41),
respectively. On the absolute scale (Figure 1), this repre-
sented an excess of 4 (95% CI: 2, 5) deaths among the least
wealthy, an excess of 2 (95% CI: 0, 3) deaths among
quintiles 1 and 2, and an excess of 1 (95% CI: 0, 3 and
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Male 46.8 42.4 47.9 48.6 48.0 48.3 48.8
Female 53.2 57.6 52.1 51.5 52.0 51.7 51.2
Race. %
White 51.7 38.6 47.1 57.6 63.8 75.0 86.3
Nonwhite 48.3 61.4 52.9 42.4 36.2 25.0 13.7
Education, %
Less than high school 25.3 30.3 27.8 19.3 22.5 17.3 12.5
High school graduate 39.0 36.7 45.0 40.9 39.5 38.6 36.7
Greater than high school 35.8 33.0 27.2 39.8 38.0 44.0 50.8
Marital status, %
Never married 21.9 43.2 33.1 21.1 12.3 8.6 5.4
Married 62.8 37.6 49.6 65.5 74.3 79.9 84.8
Widowed, divorced, or
separated
15.4 19.2 17.3 13.4 13.4 11.5 9.8
Mean age, years (SD) 37.0 (15.1) 31.4 (12.6) 30.9 (12.4) 33.1 (12.6) 37.4 (14.1) 41.8 (14.6) 48.1 (15.1)
Mean income, dollars (SD) 33,848 (37,208) 20,690 (24,289) 22,915 (19,609) 32,581 (27,342) 37,192 (26,295) 44,797 (33,188) 61,894 (75,873)
Median wealth, dollars
(25%, 75%)




16.4 19.8 14.2 11.9 14.0 12.6 12.1
Risk of deathc 8.1 5.7 5.4 6.2 7.9 10.6 17.7
Abbreviation: SD, standard deviation.
a Total sample size for bivariate analysis is 23,217. This is the full sample of all heads and partners minus those who are missing wealth data at their baseline visit.
b Prevalence of poor health status at baseline visit by wealth quintile at baseline visit.






















































95% CI: 0, 2, respectively) death among those in quintiles
3 and 4 per 1,000 persons.
The stratified analysis in Table 4 showed that women in
the least wealthy group had an increased risk of 90% relative
to that for the wealthiest women (95% CI: 1.32, 2.72), while
women in quintile 4 still had a 24% increased risk of death
(95% CI: 0.92, 1.67). The models for men, whites, and non-
whites revealed an increased risk of death among the lowest
wealth quintile (RR ¼ 1.66, 95% CI: 1.22, 2.27, RR ¼ 1.78,
95% CI: 1.26, 2.53, RR ¼ 1.49, 95% CI: 1.03, 2.15, respec-
tively), with a declining risk among higher wealth quintiles.
There was an excess of 6 deaths among men, 4 among
whites and nonwhites, and 3 among women in the least
wealthy group (95% CI: 1, 10 for men; 95% CI: 1, 6
for whites; 95% CI: 1, 8 for nonwhites, and 95% CI: 1, 5
for women, respectively). Trend tests in both the SRH and
mortality models showed a significant dose response except
in models limited to nonwhites. Group or chunk tests for
wealth were significant for all models. Refer to Web Table 4
for trend and group test results.
DISCUSSION
As hypothesized, in our study wealthier individuals re-
ported being healthier and had lower mortality. We also
hypothesized that the effects would be stronger for women
and nonwhites. Stratified SRH and mortality models re-
vealed that wealthier men, women, and whites reported bet-
ter health and lower mortality, but this was not the case for
nonwhites (as evidenced by results from trend tests) on both
the absolute and relative scales. We did, however, see larger
magnitudes in the point estimates for women relative to
men.
Our findings for nonwhites are likely because of the lim-
ited distribution of wealth among minorities. The un-
weighted data in Table 3 show that some of the wealthiest
nonwhites would only correspond to quintile 3 among
whites. This lack of variability in wealth among nonwhites
makes it difficult to detect an association between wealth
and health among this subgroup. Others have suggested that,
because of racism and discrimination, high socioeconomic
status does not afford the same health benefits among mi-
norities as it does for whites, another possible explanation
for our results (33). Our findings for gender, however, are
consistent with those from prior research (34). We found
that there were more cases of poor health among women
compared with men (higher morbidity), but for the poorest


































Figure 1. Risk differences and 95% confidence intervals per 1,000 persons for poor/fair self-rated health and mortality by wealth quintile for the
total population, Panel Study on IncomeDynamics, United States, 1984–2005. Both models were adjusted for baseline covariates and time-varying
income and marital status. The mortality model was also adjusted for time-varying self-rated health (SRH).
Table 2. Risk Ratios and 95% Confidence Intervals for the
Association Between Wealth and Poor/Fair Self-rated Health and
Wealth and Mortality for the Total Population, Panel Study of Income
Dynamics, United States, 1984–2005
SRH (n 5 14,533) Mortality (n 5 21,479)
RR 95% CI RR 95% CI
0 wealth 1.42 1.17, 1.74 1.62 1.29, 2.05
Quintile 1 1.44 1.21, 1.72 1.29 1.03, 1.62
Quintile 2 1.19 1.00, 1.42 1.31 1.05, 1.64
Quintile 3 1.20 1.02, 1.41 1.26 1.03, 1.55
Quintile 4 1.16 1.00, 1.36 1.17 0.97, 1.41
Quintile 5 1.00 Referent 1.00 Referent
Abbreviations:CI, confidence interval;RR, risk ratio;SRH, self-rated
health.
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Several mechanisms have been proposed for how low
socioeconomic status impacts health outcomes. The less
wealthy may be more subject to poor physical and social
environments, which can encourage health-damaging expo-
sures (35). In addition, the lack of a safety net associated
with having little or no wealth can cause chronic stress
among the poor, which in turn can trigger a series of bi-
ologic events, through central nervous system activation of
autonomic, neuroendocrine, and immune responses result-
ing in poor health (36).
Previous studies on wealth and mortality (2–7) and on
wealth and SRH (13, 14) found results similar to ours. There
were, however, 2 US studies that found no association be-
tween wealth and mortality and several econometric analy-
ses that found little support for the conclusion that low
levels of wealth were associated with poor health (17–20).
Instead, these papers suggested the opposite, that poor
health caused declines in wealth (17, 18, 20). One study
suggested that an important mediator, baseline health status,
was the main driver of mortality, and socioeconomic status
was less relevant among an elderly cohort (37), while other
studies used short follow-up periods to assess the question
of reverse causation (17–20, 38). A serious change in health
status is likely to have an immediate effect on a household’s
financial well being, evidenced by the fact that most per-
sonal bankruptcies were caused by illness of a family mem-
ber (in 2007 over 60%) (39). Therefore, a longer follow-up
period may be needed to see the effects of low wealth on
poor health.
By using longitudinal data with an extensive follow-up
and a method that controls for time-varying confounding,
we presented estimates that corroborate the hypothesis that
low levels of wealth are associated with poor health per-
ceived health status. Other studies with long follow-up times
further corroborated our results (13).
Limitations of our study included selection bias caused by
the exclusion of baseline cases in the SRH analysis. Those
in poor health were more likely to be older and less wealthy.
Thus, our effect estimates may be biased downward toward
the null and may underestimate the true effect (40). In ad-
dition, baseline cases of poor SRH were excluded from the
analysis to improve inference; however, given measurement
error, the subjective nature of SRH, and the lack of SRH
data prior to 1984, we were unable to create a truly
Table 3. Risk Ratios, Risk Differences,a and 95% Confidence Intervals for the Association
Between Poor/Fair Self-rated Health and Wealth by Gender and Race, Panel Study of Income









RR 95% CI RR 95% CI RR 95% CI RR 95% CI
0 wealth 1.41 1.02, 1.96 1.73 1.33, 2.25 1.89 1.47, 2.44 0.97 0.75, 1.25
Quintile 1 1.38 1.09, 1.75 1.82 1.43, 2.31 1.63 1.29, 2.06 0.97 0.76, 1.24
Quintile 2 1.25 0.99, 1.58 1.47 1.16, 1.87 1.33 1.07, 1.65 0.86 0.67, 1.10
Quintile 3 1.13 0.91, 1.41 1.55 1.23, 1.95 1.14 0.93, 1.41 0.85 0.66, 1.08
Quintile 4 1.12 0.90, 1.38 1.26 1.01, 1.56 1.03 0.84, 1.26 0.85 0.67, 1.08
Quintile 5 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent
RD 95% CI RD 95% CI RD 95% CI RD 95% CI
0 wealth 21 9, 33 25 14, 37 22 11, 33 2 14, 18
Quintile 1 14 4, 24 25 15, 35 17 9, 25 0 15, 15
Quintile 2 11 2, 20 15 6, 23 10 3, 16 8 22, 6
Quintile 3 5 3, 13 17 9, 26 5 1, 10 7 21, 7
Quintile 4 5 3, 12 8 1, 15 1 4, 6 8 22, 6
Quintile 5 Referent Referent Referent Referent
Abbreviations: CI, confidence interval; Q, quintile; RD, risk difference; RR, risk ratio.
a Per 1,000 persons.
b All models adjusted for baseline covariates and time-varying income and marital status.
c Unweighted cutpoints for wealth quintiles that correspond to the wealth distribution among
men: Q1 ($1–$12,902); Q2 ($12,903–$44,515); Q3 ($44,516–$104,860); Q4 ($104,861–
$262,122); Q5 ($262,123). The average debt for the male population was $15,845.
d Unweighted cutpoints for wealth quintiles that correspond to the wealth distribution among
women: Q1 ($1–$10,557); Q2 ($10,558–$39,160); Q3 ($39,161–$94,369); Q4 ($94,370–
$238,810); Q5 ($238,811). The average debt for the female population was $14,037.
e Unweighted cutpoints for wealth quintiles that correspond to the wealth distribution among
whites: Q1 ($1–$20,762); Q2 ($20,763–$67,303); Q3 ($67,304–$149,573); Q4 ($149,574–
$334,019); Q5 ($334,020). The average debt for the white population was $18,288.
f Unweighted cutpoints for wealth quintiles that correspond to the wealth distribution among
nonwhites: Q1 ($1–$5,047); Q2 ($5,048–$18,730); Q3 ($18,731–$44,531); Q4 ($44,532–
$98,336); Q5 ($98,337). The average debt for the nonwhite population was $10,774.
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‘‘disease-free’’ cohort. Therefore, the possibility for reverse
causation still exists.
Another limitation in the mortality analysis was the rela-
tively high level of attrition in the Panel Study of Income
Dynamics (about 3% per year, cumulatively about 50%
since the inception of the study) (41). Respondents who
were lost to follow-up were included in the analysis and
censored at their last time point; however, their mortality
status remained unknown. Differential mortality between
censored and uncensored respondents (e.g., censored indi-
viduals had higher mortality rates and were less wealthy)
would result in bias toward the null and an underestimation
of the real mortality risk. In an intensive follow-up effort,
the Panel Study of Income Dynamics found that up to 14%
of censored participants could be deceased, thus potentially
introducing bias from uncounted deaths (22).
Regardless of the close conceptual association between
income and wealth, we believed that adjusting for income
was necessary in order to understand the true effect of
wealth on these health outcomes. Empirically, there is
a moderate correlation between income and wealth in the
Panel Study of Income Dynamics (on average, r ¼ 0.41),
which has been noted elsewhere (1). In sensitivity analysis,
SRH models that excluded both baseline and time-varying
income revealed risk ratios of a substantially larger magni-
tude, suggesting that income attenuated the effect of wealth
on SRH. Thus, at the very least, our results provide conser-
vative estimates of the wealth-health association.
Finally, some have questioned the usefulness of SRH as
a health outcome for assessing social inequalities (42–44)
and for etiologic research (45). The use of SRH in our study,
however, may be more justified because of the well-
measured wealth variable (which many other health studies
lack) coupled with limited health information in the Panel
Study of Income Dynamics.
There were several strengths to our study. First, as noted
above, wealth data in the Panel Study were rigorously
and comprehensively measured (23). Many epidemiologic
studies measure wealth crudely, resulting in invalid or
underestimated results (46). In addition, our extensive
Table 4. Risk Ratios, Risk Differences,a and 95% Confidence Intervals for the Association










RR 95% CI RR 95% CI RR 95% CI RR 95% CI
0 wealth 1.66 1.22, 2.27 1.90 1.32, 2.72 1.78 1.26, 2.53 1.49 1.03, 2.15
Quintile 1 1.27 0.94, 1.72 1.56 1.10, 2.21 1.42 1.06, 1.90 1.19 0.80, 1.77
Quintile 2 1.21 0.90, 1.63 1.71 1.21, 2.43 1.23 0.91, 1.66 1.03 0.67, 1.58
Quintile 3 1.13 0.87, 1.47 1.64 1.18, 2.27 1.21 0.93, 1.57 1.49 1.02, 2.18
Quintile 4 1.11 0.86, 1.44 1.24 0.92, 1.67 1.05 0.82, 1.35 1.40 0.95, 2.05
Quintile 5 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent
RD 95% CI RD 95% CI RD 95% CI RD 95% CI
0 wealth 6 1, 10 3 1, 5 4 1, 6 4 1, 8
Quintile 1 3 1, 6 2 0.4, 4 2 0.2, 4 2 2, 5
Quintile 2 2 2, 5 3 1, 4 1 1, 3 0.3 3, 4
Quintile 3 1 3, 4 2 1, 4 1 0.4, 3 4 0.3, 8
Quintile 4 0.4 3, 3 1 0.3, 2 0.3 1, 2 3 0.4, 7
Quintile 5 Referent Referent Referent Referent
Abbreviations: CI, confidence interval; Q, quintile; RD, risk difference; RR, risk ratio.
a Per 1,000 persons.
b All models adjusted for baseline covariates and time-varying income, marital status, and
general health status.
c Unweighted cutpoints for wealth quintiles that correspond to the wealth distribution among
men: Q1 ($1–$12,902); Q2 ($12,903–$44,515); Q3 ($44,516–$104,860); Q4 ($104,861–
$262,122); Q5 ($262,123). The average debt for the male population was $15,845.
d Unweighted cutpoints for wealth quintiles that correspond to the wealth distribution among
women: Q1 ($1–$10,557); Q2 ($10,558–$39,160); Q3 ($39,161–$94,369); Q4 ($94,370–
$238,810); Q5 ($238,811). The average debt for the female population was $14,037.
e Unweighted cutpoints for wealth quintiles that correspond to the wealth distribution among
whites: Q1 ($1–$20,762); Q2 ($20,763–$67,303); Q3 ($67,304–$149,573); Q4 ($149,574–
$334,019); Q5 ($334,020). The average debt for the white population was $18,288.
f Unweighted cutpoints for wealth quintiles that correspond to the wealth distribution among
nonwhites: Q1 ($1–$5,047); Q2 ($5,048–$18,730); Q3 ($18,731–$44,531); Q4 ($44,532–
$98,336); Q5 ($98,337). The average debt for the nonwhite population was $10,774.
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longitudinal data allowed us to explore the question of
wealth and health from a life-course perspective. Many
studies of wealth and health have used cross-sectional data,
and several longitudinal studies had relatively short follow-
up times. A related advantage was our use of the marginal
structural model as the analytical technique. Comparing es-
timates from the marginal structural model with those from
the traditional approach (refer toWeb Table 5) indicated that
traditional estimates for mortality were closer to the null,
while estimates were similar for SRH. Therefore, it appears
that time-varying confounding was stronger for mortality
compared with the SRH models. The use of the marginal
structural model presumes a manipulable exposure and a re-
alistic intervention regime (47). Since wealth distributions
are partly determined by government policies such as
tax laws, this assumption of manipulability is reasonable.
However, given that some unmeasured confounding is
likely, wealth is not randomizable, the possibility for reverse
causation still exists, and the causal interpretation of our
estimates is limited. Nonetheless, we believe our study is
an improvement over previous research.
In conclusion, after control for income and education, our
study found a consistent gradient between wealth and health
overall and among men, women, and whites. That is, wealth
captures something different from income and education
that should be independently evaluated not only to under-
stand how socioeconomic status impacts health but also to
determine how to prevent poor health.
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